Effect of imidafenacin on nocturia and sleep disorder in patients with overactive bladder

Urologia Internationalis

Volumn 89, Issue 2, 2012, Pages 215-221

  Wada, Naoki ^a   Watanabe, Masaki ^a   Kita, Masafumi ^a   Matsumoto, Seiji ^a   Osanai, Hiroaki ^b   Yamaguchi, Satoshi ^b   Numata, Atsushi ^b   Fujisawa, Makoto ^c   Saga, Yuji ^c   Hou, Kyokushin ^c   Iuchi, Hiromitsu ^d   Niibori, Daisuke ^e   Kura, Tatsuhiko ^f   Taniguchi, Akihisa ^g   Kunieda, Manabu ^g   Nakata, Yasunobu ^g   Kakizaki, Hidehiro ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b Hokkaido Social Welfare Association Furano Hospital   (Japan)

^c Fukagawa City Hospital   (Japan)

^d Hokushinkai Megumino Hospital   (Japan)

^e Department of Urology   (Japan)

^f Wakkanai City Hospital   (Japan)

^g Nakata Urologic ^*  (Japan)

Author keywords

Imidafenacin; Nocturia; Overactive bladder; Sleep disorder

Indexed keywords

IMIDAFENACIN;

ADULT; AGED; ARTICLE; CONSTIPATION; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOCTURIA; OVERACTIVE BLADDER; PITTSBURGH SLEEP QUALITY INDEX; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SLEEP DISORDER; SYMPTOM; TREATMENT OUTCOME; XEROSTOMIA;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; NOCTURIA; POLYURIA; SLEEP; SLEEP DISORDERS; TIME FACTORS; URINARY BLADDER, OVERACTIVE; URODYNAMICS;

EID: 84866236278     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000339750     Document Type: Article

References (24)

1. Homma Y, Yamaguchi O, Hayashi K, Neurogenic Bladder Society Committee: Epidemiologic survey of lower urinary tract symptoms in Japan. Urology 2006; 68: 560-564.
2. Yoshimura K, Terada N, Matsui Y, Terai A, Kinukawa N, Arai Y: Prevalence of and risk factors for nocturia: Analysis of a health screening program. Int J Urol 2004; 11: 282- 287.
3. Nakagawa H, Niu K, Hozawa A, Ikeda Y, Kaiho Y, Ohmori-Matsuda K, et al: Impact of nocturia on bone fracture and mortality in older individuals: A Japanese longitudinal cohort study. J Urol 2010; 184: 1413-1418.
4. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al: The standardization of the terminology of lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-178.
5. Homma Y, Paick JS, Lee JG, Kawabe K, Japanese and Korean Tolterodine Study Group: Clinical efficacy and tolerability of extended- release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: A randomized, placebo-controlled trial. BJU Int 2003; 92: 741-747.
6. Chapple CR, Rechberger T, Al-Shukri S, Meffan P, Everaert K, Huang M, et al: Randomized, double-blind, placebo- and tolterodine- controlled trial of the once-daily antimuscarinic agent solifenacin in patients with overactive bladder. BJU Int 2004; 93: 303-310.
7. Kaplan SA, Roehrborn CG, Dmochoi R, Rovner ES, Wang JT, Guan Z: Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia. Urology 2006; 68: 328-332.
8. Rackley R, Weiss JP, Rovner ES, Wang JT, Guan Z: Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology 2006; 67: 731- 736.
9. Yamaguchi O, Marui E, Kakizaki H, Itoh N, Yokota T, Okada H, et al: Randomized, double- blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder. BJU Int 2007; 100: 579- 587.
10. Kobayashi F, Yageta Y, Yamazaki T, Wakabayashi E, Inoue M, Segawa M, et al: Pharmacological effects of imidafenacin (KRP- 197/ONO-8025), a new bladder selective anti- cholinergic agent, in rats. Comparison of effects on urinary bladder capacity and contraction, salivary secretion and performance in the Morris water maze task. Arzneimittelforschung 2007; 57: 147-154.
11. Homma Y, Yamaguchi O, Imidafenacin Study Group: A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder. Int J Urol 2009; 16: 499-506.
12. Yamaguchi O, Nishizawa O, Takeda M, Yokoyama O, Homma Y, Kakizaki H, et al: Clinical guidelines for overactive bladder. Int J Urol 2009; 16: 126-142.
13. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ: The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213.
14. Doi Y, Minowa M, Uchiyama M, Okawa M, Kim K, Shibui K, et al: Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects. Psychiatry Res 2000; 97: 165-172.
15. Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, et al: A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: Results of the STAR trial. Eur Urol 2005; 48: 464-470.
16. Weiss JP, Blaivas JG, Jones M, Wang JT, Guan Z, 037 Study Group: Age related pathogenesis of nocturia in patients with overactive bladder. J Urol 2007; 178: 548-551.
17. Sugaya K, Nishijima S, Oda M, Owan T, Miyazato M, Ogawa Y: Biochemical and body composition analysis of nocturia in the elderly. Neurourol Urodyn 2008; 27: 205-211.
18. Watanabe N, Akino H, Tanaka I, Nagase K, Yokoyama O: Antidiuretic effect of anticholinergic agents depend on c-fiber afferent nerves in the bladder. 40th Annu Meet Int Continence Soc, Toronto, 2010, abstract 493.
19. Brubaker L, FitzGerald MP: Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms. Int Urogynecol J 2007; 18: 737- 741.
20. Yokoyama O, Yamaguchi O, Kakizaki H, Itoh N, Yokota T, Okada H, et al: Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: Impact on sleep evaluated by bladder diary. J Urol 2011; 186: 170-174.
21. Bliwise DL, Foley DJ, Vitiello MV, Ansari FP, Ancoli-Israel S, Walsh JK: Nocturia and disturbed sleep in the elderly. Sleep Med 2009; 10: 540-548.
22. Coyne KS, Zhou Z, Bhattacharyya SK, Thompson CL, Dhawan R, Versi E: The prevalence of nocturia and its effect on healthrelated quality of life and sleep in a community sample in the USA. BJU Int 2003; 92: 948-954.
23. Diefenbach K, Arold G, Wollny A, Schwantes U, Haselmann J, Roots I: Effects on sleep of anticholinergics used for overactive bladder treatment in healthy volunteers aged 1 50 years. BJU Int 2005; 95: 346-349.
24. Wada N, Watanabe M, Kita M, Osanai H, Yamaguchi S, Numata A, et al: Efficacy and safety of propiverine and solifenacin for the treatment of female patients with overactive bladder: A crossover study. LUTS 2011; 3: 36- 42.